Poseida Therapeutics (PSTX)
(Real Time Quote from BATS)
$3.63 USD
+0.29 (8.68%)
Updated Jul 25, 2024 03:50 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.43 |
EPS Last Quarter | -0.25 |
Last EPS Surprise | 41.86% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.61 |
Next Year | -1.94 |
EPS (TTM) | -1.19 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 13.75M | 13.75M | 69.39M | 22.50M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 15.00M | 15.00M | 73.14M | 35.00M |
Low Estimate | 12.50M | 12.50M | 65.64M | 10.00M |
Year ago Sales | 20.01M | 9.35M | 64.70M | 69.39M |
Year over Year Growth Est. | -31.28% | 47.06% | 7.24% | -67.57% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.43 | -0.40 | -1.61 | -1.94 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.43 | -0.46 | -1.92 | -2.00 |
High Estimate | -0.38 | -0.27 | -1.18 | -1.27 |
Low Estimate | -0.47 | -0.46 | -1.92 | -2.54 |
Year ago EPS | -0.32 | -0.35 | -1.37 | -1.61 |
Year over Year Growth Est. | -34.38% | -14.29% | -17.52% | -20.14% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.43 | -0.40 | -1.61 | -1.94 |
7 Days Ago | -0.43 | -0.40 | -1.61 | -1.94 |
30 Days Ago | -0.43 | -0.40 | -1.61 | -1.94 |
60 Days Ago | -0.43 | -0.40 | -1.61 | -1.94 |
90 Days Ago | -0.44 | -0.42 | -1.77 | -1.92 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.43 | -0.40 | -1.61 | -1.94 |
Zacks Consensus Estimate | -0.43 | -0.40 | -1.61 | -1.94 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.25 | -0.27 | -0.35 | -0.32 | NA |
Estimate | -0.43 | -0.36 | -0.29 | -0.53 | NA |
Difference | 0.18 | 0.09 | -0.06 | 0.21 | 0.11 |
Surprise | 41.86% | 25.00% | -20.69% | 39.62% | 21.45% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more